Antihypertensive Medications and PTSD Incidence in a Trauma Cohort

Jaimie L. Gradus, DMSc, DSc; Meghan L. Smith, PhD; Péter Szentkúti, MSc; Anthony J. Rosellini, PhD; Erzsébet Horváth-Puhó, PhD; Timothy L. Lash, DSc, MPH; Sandro Galea, MD, DrPH; Paula P. Schnurr, PhD; Jennifer A. Sumner, PhD; Henrik T. Sørensen, MD, DMSc

J Clin Psychiatry 2023;84(5):22m14767

This content is restricted to subscribers

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

Author Affiliations

Department of Epidemiology, Boston University School of Public Health, Massachusetts
Department of Psychiatry, Boston University School of Medicine, Massachusetts
Corresponding Author: Jaimie L. Gradus, DMSc, DSc, Boston University School of Public Health, 715 Albany St T317E, Boston, MA 02118 ([email protected]).
Department of Epidemiology, Boston University School of Public Health, Massachusetts
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
Department of Epidemiology, Boston University School of Public Health, Massachusetts
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia
Department of Epidemiology, Boston University School of Public Health, Massachusetts
Executive Division, National Center for PTSD, White River Junction, Vermont
Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
Department of Psychology, University of California, Los Angeles
Department of Epidemiology, Boston University School of Public Health, Massachusetts
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark

References (30)

Sumner JA, Cleveland S, Chen T, et al. Psychological and biological mechanisms linking trauma with cardiovascular disease risk. Transl Psychiatry. 2023;13(1):25. PubMed CrossRef
Argolo FC, Cavalcanti-Ribeiro P, Netto LR, et al. Prevention of posttraumatic stress disorder with propranolol: a meta-analytic review. J Psychosom Res. 2015;79(2):89–93. PubMed CrossRef
Cojocariu SA, Maștaleru A, Sascău RA, et al. Neuropsychiatric consequences of lipophilic beta-blockers. Medicina (Kaunas). 2021;57(2):155. PubMed CrossRef
Pitman RK, Sanders KM, Zusman RM, et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry. 2002;51(2):189–192. PubMed CrossRef
Seligowski AV, Duffy LA, Merker JB, et al. The renin-angiotensin system in PTSD: a replication and extension. Neuropsychopharmacology. 2021;46(4):750–755. PubMed CrossRef
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. American Psychiatric Association Publishing; 2013.
Armstrong C, Kapolowicz MR. A preliminary investigation on the effects of atenolol for treating symptoms of anxiety. Mil Med. 2020;185(11–12):e1954–e1960. PubMed CrossRef
Garakani A, Mathew SJ, Charney DS. Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J Med. 2006;73(7):941–949. PubMed
Levy A, Kadar T, Dachir S. An animal model for studying therapeutic drugs against post-traumatic stress disorder. Mil Med. 2001;166(suppl):74–75. PubMed CrossRef
Verma M, Bali A, Singh N, et al. Investigating the role of nisoldipine in foot-shock-induced post-traumatic stress disorder in mice. Fundam Clin Pharmacol. 2016;30(2):128–136. PubMed CrossRef
Colbourne L, Harrison PJ. Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders. Mol Psychiatry. 2022;27(9):3904–3912. PubMed CrossRef
Khoury NM, Marvar PJ, Gillespie CF, et al. The renin-angiotensin pathway in posttraumatic stress disorder: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms. J Clin Psychiatry. 2012;73(6):849–855. PubMed CrossRef
Nylocks KM, Michopoulos V, Rothbaum AO, et al. An angiotensin-converting enzyme (ACE) polymorphism may mitigate the effects of angiotensin-pathway medications on posttraumatic stress symptoms. Am J Med Genet B Neuropsychiatr Genet. 2015;168B(4): 307–315. PubMed CrossRef
Marvar PJ, Goodman J, Fuchs S, et al. Angiotensin type 1 receptor inhibition enhances the extinction of fear memory. Biol Psychiatry. 2014;75(11):864–872. PubMed CrossRef
Quiñones MM, Maldonado L, Velazquez B, et al. Candesartan ameliorates impaired fear extinction induced by innate immune activation. Brain Behav Immun. 2016;52:169–177. PubMed CrossRef
Saavedra JM, Sánchez-Lemus E, Benicky J. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications. Psychoneuroendocrinology. 2011;36(1):1–18. PubMed CrossRef
Shekhar A. Angiotensin type 1 receptor antagonists-a novel approach to augmenting posttraumatic stress disorder and phobia therapies? Biol Psychiatry. 2014;75(11):836–837. PubMed CrossRef
Stein MB, Jain S, Simon NM, et al; LOSe-PTSD Investigators. Randomized, placebo-controlled trial of the angiotensin receptor antagonist losartan for posttraumatic stress disorder. Biol Psychiatry. 2021;90(7):473–481. PubMed CrossRef
Gradus JL, Rosellini AJ, Szentkúti P, et al. Using Danish national registry data to understand psychopathology following potentially traumatic experiences. J Trauma Stress. 2022;35(2):619–630. PubMed CrossRef
Schmidt M, Schmidt SAJ, Sandegaard JL, et al. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. PubMed CrossRef
Mors O, Perto GP, Mortensen PB. The Danish Psychiatric Central Research Register. Scand J Public Health. 2011;39(suppl):54–57. PubMed CrossRef
Bliddal M, Broe A, Pottegård A, et al. The Danish medical birth register. Eur J Epidemiol. 2018;33(1):27–36. PubMed CrossRef
Helweg-Larsen K. The Danish register of causes of death. Scand J Public Health. 2011;39(suppl):26–29. PubMed CrossRef
World Health Organization. International Statistical Classification of Diseases and Related Health Problems: Instruction Manual. World Health Organization; 2004:2.
Svensson E, Lash TL, Resick PA, et al. Validity of reaction to severe stress and adjustment disorder diagnoses in the Danish Psychiatric Central Research Registry. Clin Epidemiol. 2015;7:235–242. PubMed CrossRef
Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. PubMed CrossRef
Wasserstein RL, Schirm AL, Lazar NA. Moving to a world beyond “p < .05.” Am Stat. 2019;73(sup 1):1–19. CrossRef
Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature. 2019;567(7748):305–307. PubMed CrossRef
Lash TL. The harm done to reproducibility by the culture of null hypothesis significance testing. Am J Epidemiol. 2017;186(6):627–635. PubMed CrossRef
McShane BB, Gal D, Gelman A, et al. Abandon statistical significance. Am Stat. 2019;73(sup 1):235–245. CrossRef